Biomarkers and Imaging: Complementary or Subtractive?

Andrea Salzano, Alberto M. Marra, Roberta D'Assante, Michele Arcopinto, Eduardo Bossone, Toru Suzuki, Antonio Cittadini

Research output: Contribution to journalReview articlepeer-review

Abstract

Heart failure is a life-threatening disease. Its prevalence is characterized by a slow, steady increase, with unacceptable high mortality. Slowing disease progression is imperative. One of the most active field is the development of novel biomarkers. Biomarkers are used in routine clinical care for diagnosis, monitoring (response to treatment), and risk stratification of patients with heart failure. In this review, we consider in 2 different sections: blood-derived and imaging biomarkers. Finally, we analyze the effect of combining these 2 categories of biomarkers available in heart failure, aiming at understanding whether their role is complementary or subtractive.

Original languageEnglish
Pages (from-to)321-331
Number of pages11
JournalHeart Failure Clinics
Volume15
Issue number2
DOIs
Publication statusPublished - Apr 2019

Keywords

  • Biomarkers
  • Cardiovascular disease
  • Heart failure
  • Imaging
  • Prognosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Biomarkers and Imaging: Complementary or Subtractive?'. Together they form a unique fingerprint.

Cite this